⌘K
Loading ticker…
Bausch Health Companies Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Bausch Health Companies Inc (BHC) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 42. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.4%, relative volume 5.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
29 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BHC is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -11.1% / -21.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
BHC is held by 2 ETFs as of Mar 2026. Top owner: VEA at 0.00% weight, $13M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VEAVanguard FTSE Developed Markets ETF | 0.00% | $13M |
| SPDWState Street SPDR Portfolio Developed World ex-US ETF | 0.01% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BHC Jan avg: -1.18% median: -4.97% win: 25% σ: 17.07% n: 4 2022-04-12 → 2026-05-29 | BHC Feb avg: 10.99% median: 11.46% win: 100% σ: 10.80% n: 4 2022-04-12 → 2026-05-29 | BHC Mar avg: -5.50% median: -10.97% win: 25% σ: 12.47% n: 4 2022-04-12 → 2026-05-29 | BHC Apr avg: -11.06% median: -16.70% win: 20% σ: 10.18% n: 5 2022-04-12 → 2026-05-29 | BHC May avg: -16.68% median: -14.53% win: 20% σ: 22.41% n: 5 2022-04-12 → 2026-05-29 | BHC Jun avg: 9.18% median: 1.85% win: 50% σ: 26.55% n: 4 2022-04-12 → 2026-05-29 (current) | BHC Jul avg: -12.10% median: -12.52% win: 25% σ: 27.01% n: 4 2022-04-12 → 2026-05-29 | BHC Aug avg: 9.86% median: 12.16% win: 50% σ: 21.15% n: 4 2022-04-12 → 2026-05-29 | BHC Sep avg: 9.63% median: 6.99% win: 50% σ: 22.02% n: 4 2022-04-12 → 2026-05-29 | BHC Oct avg: -0.28% median: 1.59% win: 50% σ: 13.69% n: 4 2022-04-12 → 2026-05-29 | BHC Nov avg: -1.43% median: -2.17% win: 50% σ: 9.18% n: 4 2022-04-12 → 2026-05-29 | BHC Dec avg: 1.85% median: 2.87% win: 50% σ: 10.88% n: 4 2022-04-12 → 2026-05-29 |